Zymeth Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 31.86%
- Profit Growth 55.38%
- Ebitda 324.20%
- Net Worth 90.30%
- Total Assets 139.14%
About Zymeth Pharmaceuticals
Zymeth Pharmaceuticals Private Limited (ZPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2019 (Five years and 11 months 4 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pankaj Parmar, Ramuben Parmar, and Vishakha Ambaliya serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299GJ2019PTC106803
- Company No.
106803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Zymeth Pharmaceuticals Private Limited offer?
Zymeth Pharmaceuticals Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Anesthetic, Anti Infective Drugs & Medicines, Antibiotic Injection, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Hand Sanitizers & Personal Hygiene, Herbal Soaps, Cardiovascular Drugs & Medication, Cardiac Drugs.
Who are the key members and board of directors at Zymeth Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Parmar  | Managing Director | 25-Feb-2019 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramuben Parmar | Director | 25-Feb-2019 | Current |
| Vishakha Ambaliya | Additional Director | 02-Dec-2023 | Current |
Financial Performance of Zymeth Pharmaceuticals.
Zymeth Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.86% increase. The company also saw a substantial improvement in profitability, with a 55.38% increase in profit. The company's net worth Soared by an impressive increase of 90.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zymeth Pharmaceuticals?
Unlock access to Zymeth Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Oubari Pharma Private LimitedPankaj Parmar is a mutual person
- Zymeth Pharmacy Private Limited
Pankaj Parmar is a mutual person
- Paamcare Pharmaceuticals Private Limited
Pankaj Parmar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zymeth Pharmaceuticals?
Unlock and access historical data on people associated with Zymeth Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zymeth Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zymeth Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.